Basic Materials / Specialty ChemicalsNSE
$1324.90
+34.30 (+2.65%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-4.4B · quality 51.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$150.8B
P/E
86.0x
↑EV/EBITDA
39.4x
↑ROE
3.3%
↑Gross Margin
39.3%
↑Debt/Equity
0.49
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.1%
FCF CAGR
—
FCF margin
-31.4%
FCF / Net income
-4.71x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.02B · net income $933.5M · FCF $-4.40B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.02B | $14.02B | $14.43B | $15.63B | $10.51B |
| Net Income | $933.5M | $933.5M | $1.29B | $1.81B | $1.52B |
| EBITDA | $4.02B | $4.02B | $4.01B | $4.28B | $3.06B |
| EPS | 8.50 | 8.50 | 11.87 | 17.40 | 15.18 |
| Gross Margin | 39.3% | 39.3% | 36.8% | 36.1% | 37.4% |
| Operating Margin | 21.4% | 21.4% | 20.9% | 23.1% | 23.3% |
| Net Margin | 6.7% | 6.7% | 8.9% | 11.6% | 14.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.49 | 0.49 | 0.39 | 0.35 | 0.48 |
| Current Ratio | 1.43 | 1.43 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.40B | $-4.40B | $-6.57B | $713.0M | $-3.18B |
| Returns | |||||
| ROE | 3.3% | 3.3% | 4.7% | 7.6% | 8.8% |
| Valuation | |||||
| P/E | 85.98 | 85.98 | 75.25 | 54.55 | 55.34 |
| EV/EBITDA | 39.35 | 39.35 | 26.17 | 24.56 | 30.11 |
| P/B | 5.11 | 5.11 | 3.50 | 4.16 | 4.88 |
| Growth & Yield | |||||
| Revenue Growth | -2.8% | -2.8% | -7.7% | 48.7% | — |
| EPS Growth | -28.4% | -28.4% | -31.8% | 14.6% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
140.0%
EPS terminal req.
$117.56
Spread vs growth
-168.4%
5Y implied EPS CAGR
75.7%
EPS terminal req.
$142.25
Spread vs growth
-104.1%
10Y implied EPS CAGR
39.0%
EPS terminal req.
$229.10
Spread vs growth
-67.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+34.2%
Start / end P/E
83.5x → 156.3x
EPS bridge
11.87 → 8.50
Residual
-24.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.